Articles

CDMO’s goal is to increase building’s aseptic manufacturing capacity. 

Vetter Pharma Commits $243 Million Toward New Production Facility in Germany

CDMO will financially commit $10.6 million toward semi-solid and non-sterile liquid production. 

Deal includes Krazati, a therapy for patients with non-small cell lung cancer.

HDA research reveals that 95% of pharma transactions move through the traditional distribution channel. 

CDMO’s Heidelberg facility will house the newly-completed manufacturing line. 

Acquisition helps expand pharma marketing reach and opens door for growth opportunities.

Packaging manufacturers partner up in effort to help tackle pharma’s demand for recyclable packaging. 

Site aims to advance regenerative medicines on a global scale.

The conference will focus on the full breadth of commercialization strategies and operations. 

Acquisition includes company’s inflammatory disease medicines.